Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.470
-0.180 (-4.93%)
Aug 20, 2026, 10:07 AM EDT - Market open
Rocket Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $10 | Buy | Maintains | $10 | +188.18% | Aug 12, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $5 | Hold | Reiterates | $5 | +44.09% | Aug 11, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | +332.28% | Aug 11, 2026 |
| Wedbush | Wedbush | Buy Reiterates $16 → $15 | Buy | Reiterates | $16 → $15 | +332.28% | Aug 11, 2026 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 11, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 11, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $12 | Buy | Maintains | $12 | +245.82% | Aug 11, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $10 | Buy | Maintains | $10 | +188.18% | Aug 4, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.